CaV1.3 is an L-type voltage-gated calcium channel implicated in several functions including gene expression, pacemaking activity, and neurotransmitter release. The gene that encodes the CaVa1-pore forming subunit of CaV1.3 (Cacna1d) is a multi-exon gene that undergoes extensive alternative splicing, which provides functional versatility to this gene across tissues and cell-types. The function and expression of several Cacna1d splice variants within the C-terminus have been previously characterized. These splice variants differ in their voltage-dependence of activation, Ca 2+ -dependent inactivation, and their sensitivity to dihydropyridines. However, less is known about alternatively spliced exons in Cacna1d located downstream of domain I and upstream of the C-terminus (e11, e22a/e22, e31a/e31b/e32). Here, we performed a systematic study to determine the developmental and cell-specific expression of several Cacna1d splice variants. We found that the cassette e11 is upregulated during brain development, and in adult cortical tissue is more abundant in excitatory neurons relative to inhibitory interneurons. This exon is also upregulated upon nerve growth factor (NGF) induced differentiation of pheochromocytoma cells, PC12. At the functional level, the splice variants resulting from e11 alternative splicing (+e11-Cacna1d and De11-Cacna1d) form functional CaV1.3 channels with similar biophysical properties in expression mammalian systems. Of the pair of mutually exclusive exons, e22a and e22, the later dominates at all stages. However, we observed a slight upregulation of e22 from embryonic to adult human brain. A second pair of mutually exclusive exons, e31a and e31b, was also studied. We found that e31a increases during brain development. Finally, the cassette exon 32 is repressed in adult brain tissue.
INTRODUCTION
More than 90 % of multi-exon genes are subject to alternative splicing in eukaryotic cells (Kelemen et al., 2013; Baralle and Giudice, 2017; Gallego-Paez et al., 2017) . This selective inclusion and exclusion of exons abounds in the mammalian nervous system (Porter et al., 2017) , and is under the control of RNA binding proteins, or splicing factors (Vuong et al., 2016; Zhang et al., 2016) . Expression and activity of splicing factors changes throughout development and across cell-types. As a result, the expression of splice variants is substantially different between newborns and adults, as well as among cellular sub-populations (Calarco et al., 2009; Grabowski, 2011; Fogel et al., 2012; Raj et al., 2014) .
The genes that encode the CaVα1 pore-forming subunit of voltage-gated calcium channels (Cacna1) are multi-exon genes subject to alternative splicing (Liao et al., 2005; Catterall, 2011; Lipscombe et al., 2013; Lipscombe and Andrade, 2015) . CaV1.3 channels regulates gene expression, sinoatrial node firing (Mangoni et al., 2003; Torrente et al., 2016) , transmitter release from auditory hair cells (Brandt et al., 2003; Baig et al., 2011) , and hormone release (Scholze et al., 2001; Marcantoni et al., 2007; Sandoval et al., 2017) . CaV1.3 channels have been implicated in various pathologies including expression mammalian systems. We determined the temporal expression of splice variants encoding for sequences within DIII (mutually exclusive exons 22a and 22) and DIV (mutually exclusive exons 31a and 31b, and cassette exon 32) of CaV1.3 in brain tissue.
Exon 22a is slightly upregulated in adult human brain. Similarly, e31a increases during brain development. In contrast, splice variants with a fusion of exon 31a and 31b, which are predicted to introduce a premature stop codon, are repressed shortly after birth. Finally, splice variants including the cassette exon 32 are dominant in adult brain tissue.
MATERIALS AND METHODS

Animals and genotyping.
All procedures involving vertebrate animals were performed according to Institutional Animal Care and Use Committee protocol at the University of New Hampshire, which follows the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) . Wilde-type C57BL6/J male mice were used in experiments unless indicated otherwise. To label PNs with the red fluorescent protein, tdTomato (tdT), we crossed CaMKIIa-Cre mice (B6.Cg-Tg(Camk2acre)T29-1Stl/J, Jax: 005359) in a mixed C57BL/6 background with Ai14 mice (B6.Cg-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze /J, Jax: 007914) in C57BL/6. To label INs with tdT, Gad2-Cre mice (Gad2 tm2(cre)Zjh /J, Jax: 010802) in C57BL/6 background were crossed with Ai14 mice. The resulting dual transgenic mouse lines CaMKIIa;tdT and Gad2;tdT were heterozygous for both alleles. Conventional toe biopsy was performed on P7-P9 pups.
Genomic DNA was extracted with Phire Animal Tissue Direct kit II (ThermoFisher Scientific, F140WH) according to manufacturer instructions. PCR for genotyping was performed with AmpliTaq Gold ® 360 mastermix (Thermo Fisher Scientific) using the following conditions: hot start of 95 0 C for 10 min, followed by 35 cycles (95 0 C, 30 s; 60 0 C, 30 s; 72 0 C, 1 min), and final step of 72 0 C for 7 min. Primers and expected products are shown in Table 1 . F-T1: GTT CTC CGT TTG CAC TCA GG  R-T1: CAG GTT CTT GCG AAC CTC AT  F-C: AGT GGC CTC TTC CAG AAA TG  R-C: TGC GAC TGT GTC TGA TTT CC   Transgene: ~ 500 bp  PCR positive control:  521 bp All primers are reported in 5' to 3' direction
Sex determination of newborns.
To determine the sex of newborn mice, we performed PCR on genomic DNA extracted from tail biopsies. We identified the Y chromosome-specific gene (Sry) using the following primers: F, 5'-TGGGACTGGTGACAATTGTC-3, and R, 5'-GAGTACAGGTGTGCAGCTCT-3. As an internal PCR control, we amplified the interleukin-3 (IL-3) gene using the following primers: F, 5'-GGGACTCCAAGCTTCAATCA-3, and R, 5'-TGGAGGAGGAAGAAAAGCAA-3 (Lambert et al., 2000) . All primers were added to the same PCR reaction. PCR conditions are as follows: hot start at 95 o C for 10 min; followed by 35 cycles of denaturing at 95 o C for 30 s, annealing at 56 o C for 30 s, and amplification at 72 o C for 30s; with a final extension cycle at 72 o C for 7 min. Expected size for Sry is 402 bp and IL-3 is 544 bp.
Cell culture.
Certified PC12 cells (ATCC, CRL1721) were grown in suspension in RPMI-1640 (Gibco, 11875-093) 
RT-PCR
1 µg of total RNA was primed with oligo-dT and reverse transcribed using Superscript IV according to manufacturer protocols (Invitrogen, 18091050). 2 µL of cDNA were used in a 50 µL PCR reaction containing Taq polymerase (Thermofisher, 4398881) and species-specific primers ( Table 2) . Cycle number was individually determined for each primer pair to amplify within the dynamic range of the PCR ( Table 2) . All PCRs were performed using the following conditions: 1 cycle of 95°C for 10 min, number of cycles according to Table 1 
Electrophysiological analysis of Cacna1d splice variants in tsA201 cells.
De11and +e11-Cacna1d splice variants were transiently expressed in human tsA201 cells with CaVb3 (Addgene, 26574), CaVa2d-1 (Addgene, 26575), and enhanced green fluorescent protein cDNAs (eGFP; BD Bioscience) as described previously (Raingo et al., 2007) . Calcium channel currents were recorded 72 hours after transfection.
Recordings from cells expressing either splice variant were interspersed, and the experimenter was blind to clone identity over the recording and analysis period. Clone identity was revealed post analysis. Standard whole-cell patch clamp recording was used to compare biophysical properties of both CaV1.3 splice variants (Raingo et al., 2007) .
External solution contained: 10 mM BaCl2, 10 mM HEPES, 135 mM tetraethylammonium (TEA) chloride, pH adjusted to 7.2 with TEA-OH (310 mOsm). Internal solution contained: 126 mM CsCl, 10 mM EGTA, 1 mM EDTA, 10 mM HEPES, 4 mM MgATP, pH 7.2 with CsOH (290 mOsm). Barium currents were evoked by voltage-steps and currents leak subtracted on-line using a P/-4 protocol. Data were sampled at 20 kHz and filtered at 2 kHz (-3 dB). All recordings were obtained at room temperature.
Fluorescence activated cell sorting (FACS)
Adult CaMKIIa;tdT and Gad2;tdT mice were deeply anesthetized with isofluorane.
After decapitation, brains were quickly removed and placed on a petri dish with Earl's Balanced Salt Solution (EBSS) (Sigma, E3024) containing 21 U/mL of papain. Cerebral cortex was rapidly dissected (< 45 s), and tissue was dissociated using a modified version of Worthington Papain Dissociating System® (Worthington Biochemical Corporation, LK003150). Tissue was incubated with papain for 45 min at 37 0 C on a rocking platform, then triturated with three sequential diameter fire-polished glass pipettes. Next, cell suspensions were centrifuged at 300 g for 5 min. After discarding supernatants, pellets were resuspended in 3 mL of EBSS containing 0.1 % of ovomucoid protease inhibitor and 0.1 % bovine serum albumin (Worthington, LK003182) to quench papain. Cell suspension was centrifuged at 270 g for 6 min and resuspended in EBSS (3 mL). tdT-expressing cells were sorted in a Sony SH800 flow cytometer using a 561-nm laser. Events were collected directly into TRIzol TM LS Reagent (ThermoFisher Scientific, 10296028). Collection was performed keeping 1:3 (v/v) sorted cell suspension: TRIzol TM LS ratio.
RT-qPCR
300 ng of total RNA extracted from sorted cells was primed with oligo-dT and reverse transcribed with Superscript IV First-Strand Synthesis System (ThermoFisher Scientific, 18091050) according to manufacturer instructions. RT-qPCR reactions were run on an ABI 7500 Fast Real-Time PCR system (Applied Biosystems) with the following conditions: 1 cycle 95° C for 2 min, 45 cycles (95° C for 15 s and 60° C for 1 min). Each sample from at least three different male mice per genotype (biological replicates) was run in triplicate (technical replicates). Ct values were determined by 7500 Software v2.3 (Applied Biosystems). To validate the identity of sorted cells Gad2 and CaMKIIa mRNAs were quantified using TaqMan® real-time PCR assays (ThermoFisher Scientific) with the following probes Mm00484623_m1 and Mm00437967_m1. mRNA levels were normalized to Gapdh using the probe Mm99999915_g1. Relative quantification of gene expression was performed with the DD-Ct method (Livak and Schmittgen, 2001 ).
Statistical analysis.
Data are presented as mean ± one standard error of the mean (s.e.m.). Student's ttests and one-way analysis of variance (ANOVA) were performed with SPSS (IBM).
Bonferroni correction was used to adjust for multiple comparisons. We used G*power (http://www.gpower.hhu. de/) to perform power analyses. To detect differences in mean values between two independent groups with 80 % power and a confidence interval of 95 %, we determined a sample-size of 3-5 was needed for each group.
RESULTS
Inclusion of e11 in the final Cacna1d mRNA is upregulated during postnatal brain development
The DI-II linker is highly variable across the major mammalian CaVa1 subunits (Catterall, 2011; Lipscombe et al., 2013) . This cytoplasmic region is important for membrane trafficking, interaction with CaVb subunits and other regulatory proteins, coupling to signaling cascades, and fine-tuning of biophysical properties of voltage-gated calcium channels (Catterall, 2000) . Cacna1d pre-mRNA contains a cassette exon or e11 (GRCm38/mm10, chr14: 30,122,938-30,136,237) that originates two CaV1.3 splice variants with differences in the DI-II linker (De11 and +e11-Cacna1d) (Zuccotti et al., 2011) . Exon 11 encodes for a 21-amino acid sequence located 47 amino acids downstream of the alpha-interaction domain (AID) in CaV1.3 ( Fig. 1A) . Exon 11 is conserved among mammalian orthologs (see Vertebrate Multiz Alignment & Conservation, 100
Species, track of the UCSC Genome Browser. Fig. 1B) . To determine the temporal pattern of e11 during postnatal brain development, we quantified the relative amounts of De11and +e11-Cacna1d in mouse whole brains from multiple ages. We found that at postnatal day 0 (P0), inclusion of e11 is rare and drastically increases between P9-P18, but stabilizes after P30 through adulthood (Fig. 1C) . To calibrate the relative amounts for De11and +e11-Cacna1d, we performed non-saturating PCR reactions on samples containing predetermined reciprocal amounts of plasmid cDNA from Cacna1d clones with and without e11. Note that predicted and experimental values are similar ( Fig. 1D ). Next, we performed RT-PCR for De11and +e11-Cacna1d in RNA samples from fetal and adult human whole brain (fWB and aWB respectively, Fig 1E) . We found that e11-Cacna1d is also rare in fWB, whereas it dominates in aWB ( Fig. 1E and (Charizanis et al., 2012) ). Our data show that inclusion of e11 in Cacna1d is upregulated during postnatal brain development in mouse and humans.
Excitatory pyramidal neurons preferentially express +e11-Cacna1d, whereas inhibitory interneurons express mostly D11-Cacna1d splice variants
We next aimed to determine what neuronal types express De11and +e11-Cacna1d splice variants in adult brain. Previous studies have shown that INs and PNs express opposite patterns of alternative splicing for several genes (Tasic et al., 2016; Zhang et al., 2016 ). Therefore, we tested if De11 and +e11-Cacna1d splice variants show differential expression in INs and PNs of adult mouse cortex. In order to do this, we performed FACS in genetically labeled neuronal populations coupled to RT-PCR ( Fig. 2A) Gad2 + = 29.33 ± 6.33, n = 3; CaMKIIa + = 1.0 ± 0.15, n = 3. Student's t-test, p = 0.009. Fig. 2B, left panel) . Similarly, CaMKIIa + cells expressed larger amounts of CaMKIIa mRNA relative to Gad2 + cells (Mean 2 -DDCt ± SE: Gad2 + = 1.00 ± 1.10, n = 3; CaMKIIa + = 76.37 ± 36.16, n = 3. Student's t-test, p = 0.008. Fig. 2B, right panel) . We next quantified the levels of De11and +e11-Cacna1d splice variants in RNA derived from Gad2 + , CaMKIIa + cells, and whole brain cortex. We found that De11-Cacna1d is dominant in INs, whereas +e11-Cacna1d dominates in PNs, interestingly this differs from whole cortex where both splice variants are expressed at similar levels (Mean % e11 ± SE : cortex = 44.59 ± 4.3, n = 3; Gad2 + = 0.62 ± 0.41, n = 3; CaMKIIa + = 84.5 ± 2.09, n = 3. ANOVA, F2,8 = 229.67, p < 0.0001. Fig. 2C ). Post hoc analysis with Bonferroni correction showed that all means are statistically significant. Our results strongly suggest that INs express De11, whereas PNs include e11 in the final Cacna1d mRNA.
Differentiation by nerve-growth factor upregulates +e11-Cacna1d in PC12 cells
During brain development, embryonic neural progenitor cells differentiate into a wide diversity of neurons to form mature neuronal circuits (Huang and Reichardt, 2001) .
Neuronal differentiation is accompanied by the determination of splicing programs, which underlie cell-type specific functions (Baralle and Giudice, 2017) . Progenitor cells are exposed to factors that induce differentiation into defined cell-types during brain development. NGF is a classical growth factor important for survival, neurite outgrowth, and sprouting of sensory, sympathetic and central cholinergic neurons (Sofroniew and Howe…, 2001) . Upon exposure to NGF, PC12 cells develop a neuronal-like phenotype.
Here we assessed if NGF influences alternative splicing of the Cacna1d pre-mRNA in PC12 cells. We found that undifferentiated PC12 cells (UD) expressed lower levels of +e11-Cacna1d relative to PC12 cells differentiated with NGF (DF) (Mean ± SE % e11. UD = 24.5 ± 0.5, n = 3; DF = 46.6 ± 1.5, n = 3. Student's t-test, p = 0.0001, Fig. 2A) . These results show that NGF induces inclusion of e11. This event nicely correlates with inclusion of e11 in adult brain and PNs, suggesting the presence of shared mechanisms to induce inclusion of e11 in the final Cacna1d mRNA.
Comparison of biophysical properties between De11 and +e11-Cacna1d splice variants in mammalian expression systems
Previous studies comparing currents of De11-CaV1.3 and +e11-CaV1.3 channels expressed in oocytes together with auxiliary subunits, CaVb1 and CaVa2d-1, showed no differences in gating between these two splice variants. Here we compared several biophysical properties between De11and +e11-Cacna1d splice variants using the mammalian expression system, tsA201 cells and in the presence of the most abundant CaVb subunit in the brain, CaVb3. Using whole-cell voltage-clamp, we measured current density ( Fig. 4A and 4B) , voltage-dependent activation and inactivation ( Fig. 4C and 4D) , as well as open state inactivation (Fig. 4E) . We used barium as charge carrier to prevent Ca 2+dependent inactivation. No statistically significant differences were found in any of the parameters that describe these biophysical properties (see table 3 ), suggesting that both De11and +e11-Cacna1d splice variants produce fully functional CaV1.3 channels with similar biophysical properties. Our findings also confirm previous studies in oocytes. 
Inclusion of exon 22 in Cacna1d pre-mRNA is upregulated in human brain development
The Cacna1d pre-mRNA contains a tandem of mutually exclusive exons that encode for S2 sequences of DIII in CaV1.3, e22a and e22 (Fig. 5A) . Genome tracks show high peaks of conservation corresponding to e22a (GRCm38/mm10, chr14: 30, 107, 107, 845. Fig . 5B ) and e22 (GRCm38/mm10, chr14: 30, 107, 107, 712. Fig . 5B ).
Previous reports have shown that e22a, but not e22, is exclusively used in adult rat brain, whereas e22 is used in auditory hair cells of rat, trout and chicken (Kollmar et al., 1997; Ramakrishnan et al., 2002) . However, alternative splicing of e22a and e22 has not been assessed in human or mouse brain. To do this, we performed RT-PCR in fWB and aWB human tissues, as well as brain tissue from newborns and adult mice (P0 and P180, respectively). We used primers that anneal to sequences within e22a and e22 (Fig. 5A) .
We found that e22a is used in P0 and P180 mouse brain, as well as fetal and adult human brain (Fig. 5B, lanes 2, 4, 8, and 10) . We also found that e22 is not present in fetal human brain, but it is slightly used in adult human brain (Fig. 5C, lanes 9 and 11) . Surprisingly, we were unable to identify e22 in either P0 or P180 mouse brains (Fig. 5C, lanes 3 and 5) .
To validate that our primers were performing properly, we PCR-amplified from genomic DNA of mouse and human samples using the same forward primer annealing to e22 (e22Fm) and a reverse primer annealing to an intronic region downstream of e22 (i22Rm).
We observed robust amplification using this set of primers, suggesting that e22Fm primer is capable of annealing the predicted cDNA target ( Fig. 5A and Fig. 5C, lanes 6 and 12) .
This data show that e22 is present in aWB, but not in fWB. In contrast, e22 is not present in either P0 or P180 mouse tissue.
Alternative processing of exons 31a, 31b and 32 of Cacna1d pre-mRNA during postnatal brain development
Exons 31a (GRCm38/mm10, chr14: 30,107,786-30,107,845) and 31b (GRCm38/mm10, chr14: 30,089,296-30,089,380) are a pair of mutually exclusive exons in the Cacna1d pre-mRNA that generate splice variants with different sequences in S3 DIV ( Fig. 6A) . However, the pattern of 31a and 31b exon usage during brain development has not been fully determined. Here we tested if e31a and e31b inclusion in the final Cacna1d mRNA changes throughout development of human and mouse brain tissues. To assess this, we PCR-amplified using a common forward primer located in e30 and two reverse primers located in either e31a or e31b (Fig. 6A) . We observed that inclusion of e31a is lower in P0 mouse brains than in P180 mouse brains (Data are mean ± SE % e31a inclusion: P0 = 3.8 ± 1.2, n =3; P180 = 53.8 ± 1.2. Student's t-test, p < 0.0001. Fig. 6B) . Similar results were found in human brain, e31a is rarely used in fetal brain, but increases in adult whole brain ( Fig. 6C, left panel) . To validate that the set of primers and PCR conditions amplify e31aand e31b-containing Cacna1d splice variants with similar efficacy, we performed PCR using reciprocal amounts of plasmid DNA containing either e31a or e31b. Our experimental values were similar to the predicted values ( Fig. 6C, right panel) . Our results suggest that inclusion of 31a increases during brain development in both mouse and human brain. Exons 31a and 31b can also be spliced in together, e31a:31b (Fig. 6A) . Inclusion of e31a:e31b is predicted to produce a shift in the reading frame, introducing a premature stop codon. We found that this splice variant is only detectable prior to P9 and in fWB. Our results show that the e31a:e31b splice variant is repressed at early stages of brain development in both mouse and human brain.
Alternative splicing of the cassette exon e32 (GRCm38/mm10, chr14: 30,082,952-30,082,997, Fig. 6A and 7A) produces Cacna1d splice variants with modifications in the extracellular loop between S3 and S4 of DIV (Fig. 7A) . We analyzed the developmental expression of e32 in samples from human and mouse brain. Because e32 can be spliced with either e31a or e31b, we performed two independent PCRs, one amplifying from e31a through e33 (Fig. 7A) , and a second one amplifying from e31b through e33 (Fig. 7C) .
Amplification from e31a through e33 resulted in four detectable splice variants, e31a:e31b:e32, e31a:e31b:De32, e31a:e32, and e31a:De32 (Fig. 7A and Fig. 7B ) in both mouse and human brain. Analysis of mouse brain tissue showed that the four 31acontaining Cacna1d splice variants mentioned above were present at P0, but the e31a:e32
Cacna1d splice variant dominates in adult whole brain (Fig. 7B) . We observed something similar in human brain, e31a-containing Cacna1d splice variants that also include e31b and e32 (e31a:31b:e32) are more abundant in fWB than in aWB, whereas e31a-containing Cacna1d splice variants that only include e32 (e31a:e31b:e32 and e31a:e32) are more abundant in adult brain than in fWB (Fig. 7B, right) . PCR-amplification from e31b through e33 allowed the detection of two splice isoforms, e31b:e32 and e31b:De32 (Fig. 7D) . In mouse brain we found that e32 is slightly repressed over brain development (Fig. 7D, left   panel) . In human tissue, we e31b:e32 is expressed at higher levels in fWB relative to aWB ( Fig. 7D, right panel) . Our results show that: i) inclusion of e32 is upregulated in adult brain when e31a is included, but it is slightly repressed when e31b is used, and ii) splice variants containing e31a:e31b are downregulated in adult brain, confirming the results above.
DISCUSSION
The Cacna1d pre-mRNA contains exons that alter sequences in DI, I-II linker, DIII and DIV and C-terminus. In this study we focused on alternative spliced exons that generate splice variants with structural differences in the I-II linker, DIII and DIV of CaV1.3. These exons are cassette e11, mutually exclusive exons 22a/22, mutually exclusive 31a/31b, and the cassette exon 32. The function of these exons is not fully understood.
However, determining their temporal and cell-specific expression is a step towards understanding their role in CaV1.3 channel activity. Mbnl2) and RNA binding protein fox homologue 1 (Rbfox1) show decreased inclusion of e11 in whole brain (Gehman et al., 2011; Charizanis et al., 2012) . Interestingly, expression of these splicing factors increases over development, and have been shown to regulate the transition from fetal to adult splicing patterns. Mbnl1 and Mbnl2 specifically repress embryonic stem cell splicing patterns and promote differentiated neuronal cell splicing patterns (Lin et al., 2006; Kalsotra et al., 2008; Venables et al., 2013) , while Rbfox1 has been shown to regulate both splicing and transcriptional networks in human neuronal development (Fogel et al., 2012; Weyn-Vanhentenryck et al., 2014; Hamada et al., 2015) . Developmental changes in L-type calcium channel function have also been observed (Ghosh et al., 1994; Flavell and Greenberg, 2008) . It is possible that splicing factors influence calcium dynamics during development by inducing the proper alternative splicing of voltage-gated calcium channel pre-mRNAs.
Regulation of
Our results show that e22a dominates in both fetal and adult whole brain of mice and human. Exon 22 was not identified in fetal human brain, but was present at low levels in adult human brain, suggesting that inclusion of e22 increases over development. The splicing factors that regulate e22a/e22 in Cacna1d pre-mRNA have not been fully characterized. Alternative splicing of the locus e31a/e31b/e32 originates up to six distinct Cacna1d splice variants. In cases where e31a:e31b is included, a change in the open reading frame is likely to occur, which is predicted to produce a premature stop codon. We also found that skipping of e32 occurs in the presence e31b, whereas inclusion of e32 occurs in the presence of e31a. The regulation of this complex alternative splicing event is not fully understood; however, analysis of RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) shows unique binding tags for the splicing factors NOVA1, NOVA2, Rbfox1, Rbfox2 and Rbfox3 (Ule et al., 2003; Weyn-Vanhentenryck et al., 2014) . This raises the possibility that these splicing factors co-regulate splicing of e31a/e31b and e32 in the Cacna1d pre-mRNA.
Functional implications and cell-specific expression De11and +e11-Cacna1d splice variants.
Our studies show that De11 and +e11-Cacna1d splice variants generate fully functional CaV1.3 channels with similar biophysical properties in mammalian expression systems. Although these results fail to point at functional differences between the two splice variants, the prime localization of e11 in the I-II linker suggests a role in membrane trafficking, coupling to signaling cascades or interaction with cytoplasmic proteins such as CaVb subunits. Furthermore, 30 % of amino acids in e11 are positively charged, and highthroughput proteomic studies suggest the presence of a conserved arginine subject to methylation and a serine subject to phosphorylation (Hornbeck et al., 2014) . Arginine methylation has been shown to regulate cell surface expression and overall activity of other ion channels (Beltran-Alvarez et al., 2013; . Future studies considering these observations will be necessary to determine the function of e11. Finally, we have demonstrated that +e11-Cacna1d is primarily expressed in PNs, whereas De11-Cacna1d dominates in GABAergic INs of cortex. Our results point at a system to study the functional relevance of this exon.
Functional implications of splice variants within DIII and DIV of CaV1.3
The Cacna1d gene has a similar genomic arrangement to the Cacna1c gene, as a result several splicing events are common to both pre-mRNAs. Therefore, functional studies on Cacna1c splice variants could provide some insights into the function of splice variants for Cacna1d. The Cacna1c pre-mRNA contains a mutually exclusive pair of exons similar to e22a and e22 in Cacna1d, e21 and e22. Splice variants containing e21 in Cacna1c show reduced sensitivity to DHPs relative to e22-including splice variants (Soldatov et al., 1995; Zühlke et al., 1998) . Previous studies comparing brain CaV1.3 channels (contains e22a) relative to heart CaV1.2 channels (contains e22) nicely demonstrated that CaV1.3 is less sensitive to DHP (Xu and Lipscombe, 2001) . It would be interesting to see if splicing of e22a/e22 also modifies the sensitivity of CaV1.3 channels to DHPs.
Interestingly, exons 31a , 31b and e32 in the Cacna1d pre-mRNA undergo alternative processing similar to e31, e32 and e33 in the Cacna1c pre-mRNA (Xu and Lipscombe, 2001) . Alternative splicing of e31, e32 and e33 has been shown to also affect the sensitivity of CaV1.2 channels to DHP (Soldatov et al., 1995; Zühlke et al., 1998) . However, the few functional studies regarding e31a, e31b and e32 in Cacna1d shed no differences in biophysical properties or DHP sensitivity (Xu and Lipscombe, 2001) . Suggesting that these exons have unique roles in CaV1.3 channels. Understanding the functional role of these exons is a future endeavor.
Regulation of alternative splicing the Cacna1d pre-mRNA by growth factors
Alternative splicing is sensitive to developmental cues carried out by neurotrophic factors such as epidermal growth factor (Zhou et al., 2012) . Furthermore, several studies have shown that signaling by growth factors regulates the activity and expression of splicing factors (Liu et al., 2003) . In this work, we report that differentiation mediated by NGF induces a splice program for Cacna1d similar to adult whole brain and excitatory neurons. Although the exact mechanism of this is yet to be determined, our data suggest that PC12 cells contain the elements necessary to link NGF to alternative splicing. Further work in both cell lines and primary cultures is needed to obtain more mechanistic insights into how NGF controls alternative splicing of the Cacna1d pre-mRNA. (chr14:30,124,696-30,136,584) from the GRCm38/mm10 mouse assembly is represented. This region contains exons 10, 11, 12, 13, 14, and 15 Currents were elicited by step depolarizations from -80 mV to 80 mV in 10 mV increments from a holding potential of -80 mV. I-V relationships were fit to data from individual cells using the product of the Boltzmann function and a straight line for estimates of activation mid-point (V1/2), slope factor (k) and reversal potential (Vrev) (See   table 3) . B) Peak current densities evoked at -10 mV from individual cells (open symbols) expressing De11and +e11-Cacna1d splice variants are shown together with averaged current density and mean ± s.e.m. (solid symbols). C) Normalized I-V from the same cells as in A. D) Steady state inactivation relationships from normalized peak current amplitudes at -10 mV following 3 s pre-pulse steps applied in 10 mV increments to potentials between -110 mV and 10 mV. Boltzmann functions were fit to each data set and mean ± SE values for both splice variants are shown. E) Open-state inactivation was measured as percentage of current that remains after 250 ms of depolarizing pulse.
Remaining current was measured at -10 and -20 mV from a holding potential of -80 mV.
Data are presented as mean ± s.e.m. is present in aWB (lane 11). gDNA from mouse (lane 6) and human (lane 12) showed robust amplification using primers to detect e22 in mouse and human brain (see Table 1 ). 
